Integral Health Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $12.2M | Buy |
|
|||||
|
2023
Q1 | $6.46M | Sell |
|
|||||
|
2022
Q4 | $3.23M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $3.17M | Buy |
|
|||||
|
2022
Q1 | $1.15M | Sell |
|
|||||
|
2021
Q4 | $2.72M | Buy |
|
|||||
|
2021
Q3 | $3.52M | Sell |
|
|||||
|
2021
Q2 | $5.94M | Sell |
|
|||||
|
2021
Q1 | $4.39M | Sell |
|
|||||
|
2020
Q4 | $6.18M | Buy |
|
|||||
|
2020
Q3 | $3.9M | Buy |
|